Biogen
BIIB
BIIB
1,096 hedge funds and large institutions have $45.8B invested in Biogen in 2020 Q1 according to their latest regulatory filings, with 112 funds opening new positions, 325 increasing their positions, 474 reducing their positions, and 101 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
0.8% less ownership
Funds ownership: 84.16% → 83.37% (-0.8%)
18% less call options, than puts
Call options by funds: $1.24B | Put options by funds: $1.51B
31% less repeat investments, than reductions
Existing positions increased: 325 | Existing positions reduced: 474
Holders
1,096
Holding in Top 10
49
Calls
$1.24B
Puts
$1.51B
Top Buyers
| 1 | +$719M | |
| 2 | +$246M | |
| 3 | +$231M | |
| 4 |
O
OrbiMed
New York
|
+$132M |
| 5 |
BlackRock
New York
|
+$122M |
Top Sellers
| 1 | -$369M | |
| 2 | -$351M | |
| 3 | -$336M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$308M |
| 5 |
ClearBridge Investments
New York
|
-$231M |